Related references
Note: Only part of the references are listed.Strategies for Glycoengineering Therapeutic Proteins
Kris Dammen-Brower et al.
FRONTIERS IN CHEMISTRY (2022)
An embeddable molecular code for Lewis X modification through interaction with fucosyltransferase 9
Taiki Saito et al.
COMMUNICATIONS BIOLOGY (2022)
O-glycosylation and its role in therapeutic proteins
Nicole Thompson et al.
BIOSCIENCE REPORTS (2022)
New Opportunities in Glycan Engineering for Therapeutic Proteins
Xiaotian Zhong et al.
ANTIBODIES (2022)
Rational engineering of an erythropoietin fusion protein to treat hypoxia
Jungmin Lee et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2021)
Glycosylation decreases aggregation and immunogenicity of adalimumab Fab secreted from Pichia pastoris
Hitomi Nakamura et al.
JOURNAL OF BIOCHEMISTRY (2021)
Post-translational modifications in proteins: resources, tools and prediction methods
Shahin Ramazi et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2021)
In Vivo Stability of Therapeutic Proteins
Joachim Schuster et al.
PHARMACEUTICAL RESEARCH (2020)
H and L Chain Affinity Maturation and/or Fab N-Glycosylation Influence Immunoreactivity toward Neutrophil Extracellular Trap Antigens in Rheumatoid Arthritis Synovial B Cell Clones
Elisa Corsiero et al.
JOURNAL OF IMMUNOLOGY (2020)
N-Glycosylation of IgG and IgG-Like Recombinant Therapeutic Proteins: Why Is It Important and How Can We Control It?
Natalia I. Majewska et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 11 (2020)
Sialidase Activity in Human Blood Serum Has a Distinct Seasonal Pattern: A Pilot Study
Victor Y. Glanz et al.
BIOLOGY-BASEL (2020)
Enhancing the stability of adalimumab by engineering additional glycosylation motifs
Mouhamad Reslan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Stefan Mereiter et al.
CANCER CELL (2019)
Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms
Ryuta Wada et al.
MABS (2019)
A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
B. Owczarek et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Glycoengineered antibodies: towards the next-generation of immunotherapeutics
Renato Mastrangeli et al.
GLYCOBIOLOGY (2019)
IgG Fc engineering to modulate antibody effector functions
Xinhua Wang et al.
PROTEIN & CELL (2018)
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product
Kyoung Hoon Lee et al.
MABS (2018)
Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region
Fleur S. van de Bovenkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Variable Domain N-linked glycans acquired During antigen-specific immune responses can contribute to immunoglobulin G antibody stability
Fleur S. van de Bovenkamp et al.
FRONTIERS IN IMMUNOLOGY (2018)
Impact of host cell line choice on glycan profile
Justin Bryan Goh et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2018)
Enhancing the sialylation of recombinant EPO produced in CHO cells via the inhibition of glycosphingolipid biosynthesis
Chan-Yeong Kwak et al.
SCIENTIFIC REPORTS (2017)
N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins
Fabian Higel et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
The Emerging Importance of IgG Fab Glycosylation in Immunity
Fleur S. van de Bovenkamp et al.
JOURNAL OF IMMUNOLOGY (2016)
Fc glycans of therapeutic antibodies as critical quality attributes
Dietmar Reusch et al.
GLYCOBIOLOGY (2015)
Asialoglycoprotein receptor mediated hepatocyte targeting - Strategies and applications
Anisha A. D'Souza et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab)
Paul W. Tebbey et al.
MABS (2015)
Molecular-scale features that govern the effects of O-glycosylation on a carbohydrate-binding module
Xiaoyang Guan et al.
CHEMICAL SCIENCE (2015)
Restricted Motion of the Conserved Immunoglobulin G1 N-Glycan Is Essential for Efficient FcγRIIIa Binding
Ganesh P. Subedi et al.
STRUCTURE (2014)
N-linked protein glycosylation in the ER
Markus Aebi
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic
Adam W. Barb et al.
NATURE CHEMICAL BIOLOGY (2011)
Erythropoietin: A Hormone with Multiple Functions
Matilde Lombardero et al.
PATHOBIOLOGY (2011)
Glycosylation of Therapeutic Proteins An Effective Strategy to Optimize Efficacy
Ricardo J. Sola et al.
BIODRUGS (2010)
Evidence of Receptor-Mediated Elimination of Erythropoietin by Analysis of Erythropoietin Receptor mRNA Expression in Bone Marrow and Erythropoietin Clearance During Anemia
Demet Nalbant et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
Alain Beck et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc
Robert M. Anthony et al.
SCIENCE (2008)
Pharmacology of darbepoetin alfa
Iain C. Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins
AM Sinclair et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
JC Egrie et al.
EXPERIMENTAL HEMATOLOGY (2003)
Rational design and engineering of therapeutic proteins
SA Marshall et al.
DRUG DISCOVERY TODAY (2003)
Glycosylation of erythropoietin affects receptor binding kinetics: Role of electrostatic interactions
RJ Darling et al.
BIOCHEMISTRY (2002)
Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds
RG Spiro
GLYCOBIOLOGY (2002)
Mannose receptor-mediated regulation of serum glycoprotein homeostasis
SJ Lee et al.
SCIENCE (2002)
Share Paper
